Bio-Rad Laboratories, Inc. (BIO)

Bio-Rad Laboratories Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	2,558	2,567	2,671	2,802	2,923	2,546
Revenue Growth (YoY)	-0.88%	-3.92%	-4.67%	-4.12%	14.81%	10.12%
Cost of Revenue	1,219	1,188	1,244	1,235	1,259	1,108
Gross Profit	1,339	1,379	1,427	1,567	1,663	1,438
Selling, General & Admin	810.8	814	841.7	827.8	851.02	798.8
Research & Development	272.7	295.9	247.4	256.9	247.34	217.76
Operating Expenses	1,084	1,110	1,089	1,085	1,098	1,017
Operating Income	255.5	269	337.8	482.6	564.74	421.33
Interest Expense	-49.1	-48.9	-49.4	-38.1	-1.55	-21.86
Interest & Investment Income	80.4	82	100.9	58.1	18.9	18.2
Currency Exchange Gain (Loss)	6.4	3.9	7.3	0.2	-2.75	-1.77
Other Non Operating Income (Expenses)	-0.6	1.6	4.9	-5.2	0.68	-1.81
EBT Excluding Unusual Items	292.6	307.6	401.5	497.6	580.01	414.08
Merger & Restructuring Charges	-31	-	-	-	-64.4	-
Gain (Loss) on Sale of Investments	-1,104	-2,650	-1,252	-5,203	4,933	4,492
Gain (Loss) on Sale of Assets	-	-	-	1.4	-	11.7
Pretax Income	-842.6	-2,343	-850.1	-4,704	5,449	4,918
Income Tax Expense	-166.7	-498.3	-212.8	-1,077	1,195	1,104
Net Income	-675.9	-1,844	-637.3	-3,628	4,254	3,814
Net Income to Common	-675.9	-1,844	-637.3	-3,628	4,254	3,814
Net Income Growth	-	-	-	-	11.54%	116.88%
Shares Outstanding (Basic)	28	28	29	30	30	30
Shares Outstanding (Diluted)	28	28	29	30	30	30
Shares Change (YoY)	-3.14%	-3.41%	-1.93%	-1.40%	0.16%	-0.08%
EPS (Basic)	-24.56	-65.36	-21.82	-121.79	142.61	128.13
EPS (Diluted)	-24.56	-65.36	-21.82	-121.79	140.83	126.47
EPS Growth	-	-	-	-	11.35%	117.04%
Free Cash Flow	336.8	289.6	218.2	81.6	535.75	476.44
Free Cash Flow Per Share	12.24	10.26	7.47	2.74	17.74	15.80
Gross Margin	52.36%	53.73%	53.42%	55.93%	56.91%	56.48%
Operating Margin	9.99%	10.48%	12.65%	17.22%	19.32%	16.55%
Profit Margin	-26.43%	-71.86%	-23.86%	-129.45%	145.57%	149.84%
Free Cash Flow Margin	13.17%	11.28%	8.17%	2.91%	18.33%	18.72%
EBITDA	417.6	420.6	483.7	619.9	702.34	559.93
EBITDA Margin	16.33%	16.39%	18.11%	22.12%	24.03%	22.00%
D&A For EBITDA	162.1	151.6	145.9	137.3	137.6	138.6
EBIT	255.5	269	337.8	482.6	564.74	421.33
EBIT Margin	9.99%	10.48%	12.65%	17.22%	19.32%	16.55%
Effective Tax Rate	-	-	-	-	21.93%	22.44%

Updated Oct 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q